OHDSI Home | Forums | Wiki | Github

Welcome to OHDSI! - Please introduce yourself

General
#643

Hello!

I am finishing up my fellowship in trauma, surgical critical care, and emergency general surgery at the University of Pennsylvania. I will be moving to Columbus, Ohio soon to start as a faculty member at The Ohio State University Wexner Medical Center.

My interests include traumatic falls, surgical infections, cervical spine injury, sepsis, and improving access to data that allows surgeons to make better decisions. I have a bit of programming experience from my undergraduate degree in computer science. I am excited to join the OHDSI community and see how I can contribute.

Regards
Andrew

#644

Hello Chris,
I am with the COVID-19 Healthcare Coalition (c19hcc.org), and we are starting an observational study to investigate just what you are describing with BCG. We planned it just today, in fact. We have the largest EHR vendors in the US cooperating, so we can access quite a lot of data.
I’m new on this forum, you might want to email me at mkramer@mitre.org
Mark Kramer

1 Like
#645

Hello to the OHDSI Community,

It’s been a while now since I first stumbled on the topic of OHDSI. Thanks to Nigel Hughes. It took a little while to grasp it. The OHDSI events in 2019, both at Erasmus MC in Rotterdam and in Bethesda, Washington were really very helpful.

Since the March event I have been asking people of our company, Global Value Web, to get more acquainted with the topic. Reason being is that we work with a lot of data for our clients across the LifeSciences value chain. As that is becoming more and more patient centric, and focused on patient outcome, OHDSI seems like an ideal bridge to the patient. An opportunity to connect healthcare with LifeSciences. And vice versa. An area where I believe our talent can be of great help.

Throughout my professional life I have been connecting people and companies digitally. Easing the communication in Babylon, so to speak. With our teams we hope to do the same with OHDSI for both HealthCare and LifeSciences.

We have presence in Europe, (NL/Italy/Swiss), US (NJ/PA/TX), and India (Chennai, Bangalore, Hyderabad & Mumbai). With all of us we are looking to expand the OHDSI Data network, and provide value additions across a broad spectrum, from technology through research related analytics. It will take time. Surely this community effort will be very helpful.

Stay safe, stay connected,

Louis

#646

Greetings, My name is Ibrahim Okich a senior Pharmacist at Getrude’s children hospital in Nairobi, Kenya and a Health IT enthusiast. My interest is in medication therapy research and pharmacovigilance. I am also a self taught software developer who develops healthcare software applications that can be used to collect data for analysis.

My interest is in leveraging technology to solve medication related issues by continuously providing information to patients, providers and using patient reported outcomes to individualize treatment and make informed decision.

My interest is in Data science, analyzing big data, noting trends and training machines through machine learning to provide decision support tools in healthcare management to providers and patients.

Thanks for this platform, I hope to gain insights on big data research and analytics in health, provide or consume new ideas. I am open to collaborate and partner with different organization and teams that might need my expertise as a pharmacist, software developer and a data scientist to be, for the benefit of a healthier population and a vision of clinical predictive analytics.

#647

Hi Odyssey Community,

I am Ambrish from Australia pursuing my PhD in medical studies, mainly involved in real-world evidence (RWE) studies based on the database. I am glad to join this knowledgeable forum of like-minded researchers from across the globe. I am looking forward to the opportunities to collaborate with other researchers here. I am interested in RWE studies, and observation studies, and meta-analysis.

One more thing, I am looking for a Stata buddy who has experience in analysis with Stata and is willing to mentor and guide a researcher like me for appropriate use of stata. :slight_smile: Please write to me if you would like to be my stata buddy/mentor

I can be reached on ambrishagastya[at]gmail.com. I will be happy to connect with other teachers, know about their interest and contribute in ways I can.

KR
Ambrish

#648

Hello @lkubendran, @jswetha, @maheswari, @Arnaud-CH31, @cba2125, @fred.lapolla, @zotydelamota, @ajyoung, @markkramerus, @LouisHendriks, @okich, @Ambrish_singh and welcome to the OHDSI community!

Some of you have already joined our weekly community calls that take place every Tuesday at 12pm ET which is a great place to get started. If you’d like to join upcoming calls, more details are available here:
https://www.ohdsi.org/web/wiki/doku.php?id=projects:ohdsi_community

Also, please check out the weekly OHDSI digest which is posted to the forums every Monday, that’s where you can find details about upcoming OHDSI meetings, OHDSI publications and updates about the community. The latest digest was posted here: Weekly OHDSI Digest 11May2020

Finally, check out the ‘New to OHDSI’ tab on ohdsi.org for more information on how to get involved and lists of upcoming OHDSI meetings.

#649

Hi Everyone!

My name is Hari Patel, and I am an independent consultant working for Immensity Consulting, Inc. I help pharma companies with the strategy and generation of real-world evidence.

Training:
PharmD
Fellowship in HEOR
Ph.D. in Pharmacoepi

I would like to help the community with prioritization of clinically relevant research questions and conducting studies.

#650

I have been involved studies based on electronic healthcare records for over 20 years. My experience is mainly in drug safety and disease epidemiology and includes the design, protocol writing, outcome and exposure definition / identification, and reporting. This work includes vaccine exposure safety and Kawasaki disease as an outcome. I am happy to use this experience where needed.

I have a research question. Exposure to COVID-19 may increase the risk of Kawasaki disease in children. Could OHDSI help to understand this association?

#651

Hi, I am Tontel Obene. I was the lead Epidemiologist/Evaluator for Mississippi Urban Research Center (MURC), currently recuperating from an accident I sustained on the job. There, I monitored and analysed data on heart disease and stroke prevention programs in the Mississippi Delta to find out their impact on the community. Mississippi Urban Research Center provides both basic and applied research into problems that plague urban communities and make this data available to policy makers.

I would like to take part in any collaborative research work. I am proficient in SPSS and SAS, but working on R. I strongly believe in the concept that “there is no I in team”.

Open to lending my expertise in whatever way I can to impact lives.

#652

Hello, I am Filipa, from Portugal.
I would be very pleased to have the chance to work with you on this challenging project. Can you help me to discover how?

Please find my short professional bio below:

Filipa Duarte-Ramos is an assistant professor at the Social Pharmacy Department, Faculty of Pharmacy, University of Lisbon, Portugal, since 2012, where she teaches since 2001.
She holds a PhD in Pharmacoepidemiology awarded by the University of Lisbon in 2012, a MSc in Epidemiology awarded by the Nova Medical School of Lisbon in 2002, and graduated in Pharmaceutical Sciences in 1994 by Faculty of Pharmacy, University of Lisbon.

Filipa’s research interests are related to the investigation of health determinants, in particular the study of the positive and negative outcomes from the use of medicines by the population. She is also interested in the study of drug utilization in special populations or conditions and health outcomes research.

Filipa currently serves as a member of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance at the European Medicines Agency (ENCePP – EMA) and was part of the Special Interest Group in Drug Safety in Pregnancy. She represents the Faculty of Pharmacy in the plenary meetings of the ENCePP since 2011.

Filipa currently serves as Epidemiology Expert of the European Medicines Agency (EMA).

She is coordinator and researcher at OPSS (Health System Portuguese Observatory) and member of Epidemiology Research Unit (EPIUnit)- Oporto Public Health Institute (ISPUP)

#653

@Gillian.Hall, @FDuarteRamos: Welcome to the family. Please scroll up a little bit. @MauraBeaton tells you how to come in and get engaged. Good luck.

1 Like
#654

Hi Everyone,

I am Dalia Dawoud. Currently working as Scientific Adviser at NICE in the UK. My interest is in economic evaluations and use of RWD to inform cost effectiveness analysis. I have experience in systematic reviews, network meta-analyses and economic modelling as well.

I look forward to actively contributing in literature reviews, study design and writing research papers for publications.

BW
Dalia

#656

Hello! I am Akari from Japan.
I am a high school student, and I study several traditional medicines.

I joined the OHDSI community because I thought this would be an essential tool to show and analyze the complicated and detailed information of the traditional medicine to use as evidence for better decisions.
I am taking the IBDP course and the data analytics just drove my attention.
I just started learning about the OHDSI and OMOP, and I am not sure what I can contribute as a newbie but I am looking forward to learn more!

#657

Hello all!

I am Thanos, my background is electrical engineering and the last 3 years I am part of the Vivante Health Software and Data Science team based in Greece. We are looking to find the best way of structuring claims/EMR data and later on questionnaire/survey data for analytics and predictive modeling. I m really happy to join this huge open source project/team and looking forward to contribute after I understand what is going around here :). So for me the next days is reading and testing out some of the tools. I ll mostly focus on CDM and the ETL processes.

Many thanks to all of you!
Thanos

1 Like
#658

Welcome @TOBENE, @ddawoud, @jopuura, @akajpn, @thanos_vidakis

Some of you joined in on yesterday’s community calls (community call take place every Tuesday at 12pm ET) which is a great place to get started. If you’d like to join upcoming calls, more details are available here: projects:ohdsi_community [Observational Health Data Sciences and Informatics]

For more details about regular OHDSI meetings and how to get involved please check out the weekly OHDSI digest which is posted to the forums every Monday. The latest digest was posted here: Weekly OHDSI Digest - 18May2020

Finally, check out the ‘New to OHDSI’ tab on ohdsi.org for more information on how to get involved and lists of upcoming OHDSI meetings. All OHDSI meetings are open to anyone interested in getting involved, so please don’t hesitate to join in :slight_smile:

2 Likes
#659

This is very helpful. Thank you so much! :+1:

#660

Thank you very much, Maura!

#661

Hi Everyone, My name is Hugh Bowie. I am long time Merger Project Manager (ask about it) that has 25 years plus in Technology (do not code , sorry) and large implementations of ERP, PeopleSoft, Payroll and HR systems. I have had the good fortune to complete work for 15 % of the fortune five hundred doing those mergers and acquisitions. I have built 5 data warehouses and can show you the scars.
My education is continuing after my retirement in 2007. BSIT, MSIT, MHA, currently pursuing a Doctorate in Capella
University School of Nursing and Healthcare Sciences or a DHA Healthcare Quality Data and Analytics.
I stumbled across this organization while doing a research project for school and decided to join. I live in Southern Georgia and come from NYC born and raised.
Pleased to meet everyone and I hope to contribute something in the future.
Many Cheers
Hugh

#662

Hello all,

I am Andrew, a data manager at Dell Medical School at UT Austin. We are upgrading our research systems and I am here to learn about OHDSI and the OMOP CDM. We are eager to learn from those who have converted their data lakes to CDM, what has worked, what has not, and all the rest!

Best regards,
Andrew

#663

Hello all,

My name is Sam, and I own a healthcare consulting company in the US. I specialize in clinical registries, primarily working with medical specialty societies. Looking forward to learning more about OHDSI, and how I can use this framework to the benefit of my clients.

t